Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

PharmaLex

PharmaLex

PharmaLex provides specialized regulatory and safety services for pharmaceutical, biotech, and medtech teams across product lifecycles.

Operating headquarters

Bad Homburg, HE, DE🇩🇪

Founded

Drug and device makers face shifting requirements across clinical development, approval, and post-market oversight in many jurisdictions. PharmaLex supports pharmaceutical, biotechnology, and medical device teams with end-to-end services spanning development strategy, regulatory submissions, pharmacovigilance, quality management, and market access, delivered through regional hubs and technology-enabled processes.

Unlike broad clinical research organizations such as IQVIA and Parexel that center on trial execution, PharmaLex concentrates on regulatory and safety compliance across the full product lifecycle. That specialist focus lets client teams outsource maintenance and submission work while keeping development capacity for new therapies.

PharmaLex - M & A Snapshot

Cencora
Acquired PharmaLex • €1.3B • Jan 3, 2023
Arbour Group
Acquired by PharmaLex • Undisclosed • Feb 11, 2020

PharmaLex - Similar Companies

R-Pharm

r-pharm.com

Express Scripts

CordenPharma

cordenpharma.com

Otsuka Pharmaceutical

otsuka.co.jp

Flexera

flexera.com

LARABICUS

larabicus.com

ChemChina

chemchina.com

Modaxo

modaxo.com

Mediktor

mediktor.com

General Medicine

generalmedicine.co

Hologic

hologic.com

Daxtra

daxtra.com

Merifix Electronics

merifix.com

ABOUT Healthcare

PharmaLex - Quick Facts

Who are PharmaLex's competitors?

Companies similar to PharmaLex include R-Pharm, Express Scripts, CordenPharma and Otsuka Pharmaceutical.

When was PharmaLex founded?

PharmaLex was founded in 1994.

Where is PharmaLex's headquarters located?

PharmaLex's headquarters is located in Bad Homburg, HE, DE.

When was PharmaLex's last funding round?

PharmaLex's most recent funding round was for €1.3B (EUR) in September 2022.

How much has PharmaLex raised to-date?

As of Sep 12, 2022, PharmaLex has raised a total of €1.3B (EUR).

PharmaLex - Classification

Industry: Healthcare Consulting
Pharmaceutical Manufacturing

Model: B2B
Customer: Enterprise